G. Bildik Et Al. , "GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro," HUMAN REPRODUCTION , vol.30, no.12, pp.2912-2925, 2015
Bildik, G. Et Al. 2015. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro. HUMAN REPRODUCTION , vol.30, no.12 , 2912-2925.
Bildik, G., Akin, N., Senbabaoglu, F., Sahin, G. N., Karahuseyinoglu, S., Ince, Ü., ... Taskiran, C.(2015). GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro. HUMAN REPRODUCTION , vol.30, no.12, 2912-2925.
Bildik, Gamze Et Al. "GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro," HUMAN REPRODUCTION , vol.30, no.12, 2912-2925, 2015
Bildik, Gamze Et Al. "GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro." HUMAN REPRODUCTION , vol.30, no.12, pp.2912-2925, 2015
Bildik, G. Et Al. (2015) . "GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro." HUMAN REPRODUCTION , vol.30, no.12, pp.2912-2925.
@article{article, author={Gamze Bildik Et Al. }, title={GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro}, journal={HUMAN REPRODUCTION}, year=2015, pages={2912-2925} }